Funded Tech Companies

StroMedix

Researching who purchased StroMedix? The company was acquired by Biogen.

Company Overview

Company Name
StroMedix
Company Status
Acquired or Merged

Contact Information

Mailing Address
One Canal Park 1120
Cambridge, MA 02141
USA
Email Address

Company Background Information

Overview
Stromedix is a clinical-stage biotechnology company committed to developing novel drugs to treat fibrotic organ failure. Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.
Profile
StroMedix LinkedIn Company Profile
Social Media
StroMedix Company Twitter Account
Company News
StroMedix News
Facebook
StroMedix on Facebook
YouTube
StroMedix on YouTube
Last Transaction
2/14/2012

Financing History

Date
Type
Amount
M&A
$562,500,000
Debt
$2,000,000
Venture Equity
$25,000,000
Venture Equity
$1,000,000


Management Team

Title
Name
Email & Social
Chairman
Dan Lynch
  Dan Lynch LinkedIn Profile  Dan Lynch Twitter Account  Dan Lynch News  Dan Lynch on Facebook
Chief Executive Officer
Michael Gilman
  Michael Gilman LinkedIn Profile  Michael Gilman Twitter Account  Michael Gilman News  Michael Gilman on Facebook
Chief Medical Officer
Brad Maroni
  Brad Maroni LinkedIn Profile  Brad Maroni Twitter Account  Brad Maroni News  Brad Maroni on Facebook
VP - R & D
Shelia Violette
  Shelia Violette LinkedIn Profile  Shelia Violette Twitter Account  Shelia Violette News  Shelia Violette on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Stromberg | Strong by Form

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary